Recent diagnostic and therapeutic innovations in heart failure management

被引：0

作者：

Gehi, AK ^{[1
]}

Pinney, SP ^{[1
]}

Gass, A ^{[1
]}

机构：

[1] CUNY Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA

来源：

MOUNT SINAI JOURNAL OF MEDICINE | 2005年 / 72卷 / 03期

关键词：

heart failure; diagnosis; therapy; innovations; review;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Although there has been substantial progress in the treatment of congestive heart failure over the last several decades, it is clear that heart failure continues to burden our aging population. As the epidemic of heart failure grows, there remains an unmistakable need for novel diagnostic and therapeutic options in its management. In this article, we review recent innovations in the management of congestive heart failure, highlighting several recent clinical trials.

引用

页码：176 / 184

页数：9

共 69 条

[1] B-type natriuretic peptide: From bench to bedside [J].

Adams, KF ;

Mathur, VS ;

Gheorghiade, M .

AMERICAN HEART JOURNAL, 2003, 145 (02) :S34-S46

[2] Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction [J].

Al-Ahmad, A ;

Rand, WM ;

Manjunath, G ;

Konstam, MA ;

Salem, DN ;

Levey, AS ;

Sarnak, MJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :955-962

[3] C-reactive protein as a predictor of improvement and readmission in heart failure [J].

Alonso-Martínez, JL ;

Llorente-Diez, B ;

Echegaray-Agara, M ;

Olaz-Preciado, F ;

Urbieta-Echezarreta, M ;

González-Arencibia, C .

EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :331-336

[4] Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH):: randomised, double-blind, placebo-controlled trial [J].

Anand, I ;

McMurray, J ;

Cohn, JN ;

Konstam, MA ;

Notter, T ;

Quitzau, K ;

Ruschitzka, F ;

Lüscher, TF .

LANCET, 2004, 364 (9431) :347-354

[5] Randomized, controlled trial of long-term moderate exercise training in chronic heart failure - Effects on functional capacity, quality of life, and clinical outcome [J].

Belardinelli, R ;

Georgiou, D ;

Cianci, G ;

Purcaro, A .

CIRCULATION, 1999, 99 (09) :1173-1182

[6] B-type natriuretic peptide predicts sudden death in patients with chronic heart failure [J].

Berger, R ;

Huelsman, M ;

Strecker, K ;

Bojic, A ;

Moser, P ;

Stanek, B ;

Pacher, R .

CIRCULATION, 2002, 105 (20) :2392-2397

[7] Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure [J].

Bozkurt, B ;

Torre-Amione, G ;

Warren, MS ;

Whitmore, J ;

Soran, OZ ;

Feldman, AM ;

Mann, DL .

CIRCULATION, 2001, 103 (08) :1044-1047

[8] Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study [J].

Burger, AJ ;

Horton, DP ;

LeJemtel, T ;

Ghali, JK ;

Torre, G ;

Dennish, G ;

Koren, M ;

Dinerman, J ;

Silver, M ;

Cheng, ML ;

Elkayam, U .

AMERICAN HEART JOURNAL, 2002, 144 (06) :1102-1108

[9] Thromboxane inhibition improves renal perfusion and excretory function in severe congestive heart failure [J].

Castellani, S ;

Paniccia, R ;

Di Serio, C ;

La Cava, G ;

Poggesi, L ;

Fumagalli, S ;

Gensini, GF ;

Serneri, GGN .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) :133-139

[10] Inflammatory markers and onset of cardiovascular events - Results from the Health ABC study [J].

Cesari, M ;

Penninx, BWJH ;

Newman, AB ;

Kritchevsky, SB ;

Nicklas, BJ ;

Sutton-Tyrrell, K ;

Rubin, SM ;

Ding, JZ ;

Simonsick, EM ;

Harris, TB ;

Pahor, M .

CIRCULATION, 2003, 108 (19) :2317-2322

← 1 2 3 4 5 6 7 →